Cadrenal Therapeutics, Inc.(CVKD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CVKD Cadrenal Therapeutics, Inc.

盘前交易 03-10 04:27:26 EDT

8.00

-0.28

-3.38%

最高8.35	最低7.86	成交量2.18万
今开8.08	昨收8.28	日振幅5.95%
总市值1,871万	流通市值1,444万	总股本233.81万
成交额17.70万	换手率1.21%	流通股本180.52万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CVKD","market":"US","secType":"STK","nameCN":"Cadrenal Therapeutics, Inc.","latestPrice":8,"timestamp":1773086400000,"preClose":8.28,"halted":0,"volume":21828,"delay":0,"changeRate":-0.033816425120772875,"floatShares":1805200,"shares":2338127,"eps":-8.189606,"marketStatus":"盘前交易","change":-0.28,"latestTime":"03-10 04:27:26 EDT","open":8.08,"high":8.35,"low":7.857,"amount":176976.141624,"amplitude":0.059541,"askPrice":10.75,"askSize":100,"bidPrice":5.67,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-8.189606,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773149400000},"marketStatusCode":1,"adr":0,"listingDate":1674190800000,"exchange":"NASDAQ","adjPreClose":8,"postHourTrading":{"tag":"盘后","latestPrice":8,"preClose":8,"latestTime":"16:29 EDT","volume":15,"amount":120,"timestamp":1773088141480,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.429949},"requestUrl":"/m/hq/s/CVKD","defaultTab":"news","newsList":[{"id":"1184343510","title":"Cadrenal Therapeutics Inc获美国FDA批准召开二期临床结束会议，共商三期注册路径","url":"https://stock-news.laohu8.com/highlight/detail?id=1184343510","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184343510?lang=zh_cn&edition=full","pubTime":"2026-02-24 21:33","pubTimestamp":1771940025,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics Inc近日成功获得美国食品药品监督管理局（FDA）的许可，将举行二期临床试验结束会议。此次会议旨在就公司即将开展的三期临床试验注册路径达成共识，为后续药物研发和上市申请奠定重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"gpt_icon":0},{"id":"1164036259","title":"Cadrenal Therapeutics公布CAD-1005二期试验结果：血栓事件显著减少，支持临床推进","url":"https://stock-news.laohu8.com/highlight/detail?id=1164036259","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164036259?lang=zh_cn&edition=full","pubTime":"2026-02-24 21:31","pubTimestamp":1771939878,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics, Inc.宣布其候选药物CAD-1005在二期临床试验中取得积极数据。结果显示，该药物能显著降低血栓事件发生率，为后续临床开发提供有力支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"gpt_icon":0},{"id":"1120797746","title":"Cadrenal Therapeutics将在2026年1月12日至15日于旧金山举行的J.P.摩根第44届年度医疗会议期间进行合作及投资者会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1120797746","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120797746?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:03","pubTimestamp":1765980198,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics将在2026年1月12日至15日于旧金山举行的J.P.摩根第44届年度医疗会议期间进行合作及投资者会议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131342.USD","LU2023250330.USD","LU1119994496.HKD","LU0106261372.USD","LU0320765489.SGD","LU2054465674.USD","IE00B1XK9C88.USD","LU2211815571.USD","LU1162221912.USD","LU1244550221.USD","IE0034235295.USD","LU0868494708.USD","LU1244550577.SGD","LU1720051017.SGD","SG9999002224.SGD","LU2023250843.SGD","LU0106831901.USD","IE00BN8TJ469.HKD","LU0211327993.USD","LU1894683264.USD","LU2430703178.SGD","LU1914381329.SGD","LU1261432733.SGD","LU2237443622.USD","BK4550","LU1496350502.SGD","LU2746668974.SGD","LU0787776722.HKD","LU2756315318.SGD","LU0265550359.USD","LU1894683348.USD","LU0496365809.HKD","LU0971096721.USD","LU0048584097.USD","LU1084165304.USD","LU0211326839.USD","LU0689472784.USD","LU0006306889.USD","LU2236285917.USD","LU1629891620.HKD","BK4588","LU0683600562.USD","LU0256863811.USD","LU2237443978.SGD","LU0149725797.USD","LU2237443549.SGD","LU0943347566.SGD","LU1551013342.USD","LU0868494617.USD","LU2756315664.SGD","IE00BKVL7J92.USD","LU0238689110.USD","IE00BDRTCR15.USD","LU1363072403.SGD","LU1116320737.USD","LU1974910355.USD","SG9999002232.USD","LU0882574139.USD","LU2237443382.USD","LU0323591593.USD","IE00BBT3K403.USD","LU2264538146.SGD","IE00B775SV38.USD","IE00BLSP4452.SGD","LU2357305700.SGD","IE00B1BXHZ80.USD","BK4566","LU1366192091.USD","BK4534","LU1670628061.USD","LU2462157665.USD","IE00BJLML261.HKD","BK4007","LU0345769631.USD","LU1116320901.HKD","LU1267930490.SGD","LU1988902786.USD","LU1496350171.SGD","LU2746668461.USD","LU0211328371.USD","LU1032466523.USD","BK4516","BK4504","BK4207","IE00B3S45H60.SGD","LU0215105999.USD","LU0820562030.AUD","IE0034235188.USD","LU0976567544.SGD","BK4533","LU2505996681.GBP","LU0820561818.USD","LU0267386448.USD","LU0265550946.USD","LU0211331839.USD","LU1548497426.USD","IE0034235303.USD","LU2552382058.USD","IE000M9KFDE8.USD","LU2381873111.SGD","BK4581","CVKD","IE00BZ1G4Q59.USD","LU0345770308.USD","LU2237443895.HKD","LU2417539215.USD","LU2592432038.USD","LU2430703251.USD","LU1145028129.USD","LU0320765646.SGD","LU2242649171.HKD","LU0820561909.HKD","LU0964807845.USD","LU1244550494.USD","LU2552382132.HKD","LU1551013425.SGD","LU0251132253.USD","IE00BJTD4V19.USD","LU0640476718.USD","LU2237443465.HKD","LU1720051108.HKD","LU2213496289.HKD","IE00BKDWB100.SGD","LU1280957306.USD","BK4585","LU1668664300.SGD","IE00BLSP4239.USD","LU0345770993.USD","LU2106854487.HKD","LU0211326755.USD","LU1917777945.USD","LU2023250504.SGD","LU0417517546.SGD","IE00BDCRKT87.USD","LU0234572021.USD","LU2430703095.HKD","LU1670627923.USD","LU0310799852.SGD","LU0070302665.USD","LU0942090050.USD","IE00BYXW3230.USD","LU0203347892.USD","LU2456880835.USD","IE00BWXC8680.SGD","IE00BJTD4N35.SGD","LU2505996509.AUD","LU0170899867.USD","LU2552382215.SGD","IE00BHPRN162.USD","LU0345769128.USD","LU0203345920.USD","IE00BFXG1179.USD","LU0208291251.USD"],"gpt_icon":0},{"id":"1198648709","title":"Cadrenal Therapeutics, Inc. - Veralox在未来商业化时有权获得收购资产全球销售的特许权使用费","url":"https://stock-news.laohu8.com/highlight/detail?id=1198648709","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198648709?lang=zh_cn&edition=full","pubTime":"2025-12-11 21:07","pubTimestamp":1765458440,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics, Inc. - Veralox在未来商业化时有权获得收购资产全球销售的特许权使用费","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CVKD"],"gpt_icon":0},{"id":"1164645722","title":"Cadrenal Therapeutics收购Vlx-1005，首个2期12-Lox抑制剂，针对肝素诱导的血小板减少症（Hit）患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1164645722","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164645722?lang=zh_cn&edition=full","pubTime":"2025-12-11 21:07","pubTimestamp":1765458427,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics收购Vlx-1005，首个2期12-Lox抑制剂，针对肝素诱导的血小板减少症（Hit）患者","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CVKD"],"gpt_icon":0},{"id":"2586294705","title":"Cadrenal Therapeutics, Inc.盘中异动 下午盘急速下挫5.44%报9.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586294705","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586294705?lang=zh_cn&edition=full","pubTime":"2025-11-27 03:38","pubTimestamp":1764185893,"startTime":"0","endTime":"0","summary":"北京时间2025年11月27日03时38分，Cadrenal Therapeutics, Inc.股票出现异动，股价快速下跌5.44%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Pasithea Therapeutics Corp.涨幅较大，Scisparc Ltd.、Pasithea Therapeutics Corp.、Kala Bio, Inc.较为活跃，换手率分别为3066.29%、1736.74%、212.17%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Pasithea Therapeutics Corp.，振幅分别为285.36%、232.70%、170.86%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc正在开发其候选药物tecarfarin，以满足抗凝治疗中尚未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127033813a7138c46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127033813a7138c46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","LENZ","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"1175022091","title":"Cadrenal Therapeutics通过收购Exithera的XIa因子抑制剂产品组合加强抗凝血管线","url":"https://stock-news.laohu8.com/highlight/detail?id=1175022091","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175022091?lang=zh_cn&edition=full","pubTime":"2025-09-15 20:04","pubTimestamp":1757937880,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics通过收购Exithera的XIa因子抑制剂产品组合加强抗凝血管线","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"gpt_icon":0},{"id":"2518240132","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘股价大跌5.04%报16.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518240132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518240132?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:35","pubTimestamp":1741613715,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时35分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速跳水5.04%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213515a26a2622&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213515a26a2622&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2516658719","title":"Cadrenal Therapeutics, Inc.盘中异动 快速下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516658719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516658719?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:54","pubTimestamp":1741017248,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时54分，Cadrenal Therapeutics, Inc.股票出现异动，股价快速下跌5.14%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235408989a24c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235408989a24c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2514320236","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘股价大涨5.12%报19.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514320236?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753102,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Cadrenal Therapeutics, Inc.股票出现波动，股价快速上涨5.12%。截至发稿，该股报19.35美元/股，成交量1510股，换手率0.08%，振幅0.00%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223142989679a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223142989679a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CVKD","BK4007","BK4139"],"gpt_icon":0},{"id":"2514892503","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘快速上涨5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514892503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514892503?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:18","pubTimestamp":1740669507,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时18分，Cadrenal Therapeutics, Inc.股票出现波动，股价急速上涨5.49%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022723182798951a89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022723182798951a89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVKD","LENZ","BK4007"],"gpt_icon":0},{"id":"2514263854","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514263854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514263854?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:34","pubTimestamp":1740584097,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时34分，Cadrenal Therapeutics, Inc.股票出现波动，股价急速拉升5.16%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226233457a25505c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226233457a25505c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVKD","BK4007","LENZ"],"gpt_icon":0},{"id":"2512611411","title":"Cadrenal Therapeutics, Inc.盘中异动 早盘大幅拉升5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512611411","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512611411?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:41","pubTimestamp":1739893303,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时41分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅上涨5.16%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218234143988a0ac9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218234143988a0ac9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","CVKD","BK4139"],"gpt_icon":0},{"id":"2510686328","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大跌5.08%报17.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510686328","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510686328?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:31","pubTimestamp":1739197869,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时31分，Cadrenal Therapeutics, Inc.股票出现异动，股价快速下挫5.08%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223110961dffb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223110961dffb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVKD","BK4007","LENZ"],"gpt_icon":0},{"id":"2509299887","title":"Cadrenal Therapeutics, Inc.盘中异动 临近午盘大幅下跌5.13%报18.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509299887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509299887?lang=zh_cn&edition=full","pubTime":"2025-02-08 00:48","pubTimestamp":1738946938,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日00时48分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速下跌5.13%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208004858abc648e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208004858abc648e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVKD","BK4007","LENZ"],"gpt_icon":0},{"id":"2509778979","title":"Cadrenal Therapeutics, Inc.盘中异动 快速下挫5.27%报18.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509778979","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509778979?lang=zh_cn&edition=full","pubTime":"2025-02-07 04:50","pubTimestamp":1738875013,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日04时50分，Cadrenal Therapeutics, Inc.股票出现波动，股价急速跳水5.27%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207045013987cc3c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207045013987cc3c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2506517844","title":"Cadrenal Therapeutics, Inc.盘中异动 大幅跳水5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506517844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506517844?lang=zh_cn&edition=full","pubTime":"2025-01-28 23:20","pubTimestamp":1738077602,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日23时20分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速跳水5.33%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282320029875713c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282320029875713c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","CVKD"],"gpt_icon":0},{"id":"2505269347","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大涨6.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505269347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505269347?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:36","pubTimestamp":1737556569,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时36分，Cadrenal Therapeutics, Inc.股票出现异动，股价快速拉升6.26%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223609986f7877&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223609986f7877&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2505204639","title":"Cadrenal Therapeutics, Inc.盘中异动 股价大涨6.32%报18.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505204639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505204639?lang=zh_cn&edition=full","pubTime":"2025-01-22 01:12","pubTimestamp":1737479534,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日01时12分，Cadrenal Therapeutics, Inc.股票出现异动，股价急速上涨6.32%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.82%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122011214abb369ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122011214abb369ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","CVKD"],"gpt_icon":0},{"id":"2503679278","title":"Cadrenal Therapeutics, Inc.盘中异动 下午盘急速拉升5.57%报16.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503679278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503679278?lang=zh_cn&edition=full","pubTime":"2025-01-16 03:38","pubTimestamp":1736969915,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日03时38分，Cadrenal Therapeutics, Inc.股票出现波动，股价快速拉升5.57%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.53%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc专注于开发一种具有孤儿药指征的新疗法——替卡法林，用于预防终末期肾病(透析中)和房颤或AFib患者的心脏源性系统性血栓栓塞(血凝块)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116033835a2234410&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116033835a2234410&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","CVKD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cadrenal.com","stockEarnings":[{"period":"1week","weight":-0.0687},{"period":"1month","weight":0.4035},{"period":"3month","weight":-0.1976},{"period":"6month","weight":-0.3962},{"period":"1year","weight":-0.5252},{"period":"ytd","weight":0.1799}],"compareEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":-0.0179},{"period":"3month","weight":-0.007},{"period":"6month","weight":0.04},{"period":"1year","weight":0.1777},{"period":"ytd","weight":-0.0054}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cadrenal Therapeutics, Inc.于2022年1月25日注册为特拉华州公司。该公司正在开发公司候选药物替卡法林，用于抗凝治疗方面未满足的需求。替卡法林是一种晚期新型口服和可逆抗凝血剂（血液稀释剂），用于预防心脏病发作、中风，以及需要慢性抗凝的罕见心血管疾病患者因血栓而死亡。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.616418},{"month":2,"riseRate":0.25,"avgChangeRate":-0.178681},{"month":3,"riseRate":0,"avgChangeRate":-0.1387},{"month":4,"riseRate":0,"avgChangeRate":-0.132322},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.019116},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.011801},{"month":7,"riseRate":0,"avgChangeRate":-0.216246},{"month":8,"riseRate":0.666667,"avgChangeRate":0.106371},{"month":9,"riseRate":0.666667,"avgChangeRate":0.247631},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.040335},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.124766},{"month":12,"riseRate":0.333333,"avgChangeRate":0.094875}],"exchange":"NASDAQ","name":"Cadrenal Therapeutics, Inc.","nameEN":"Cadrenal Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cadrenal Therapeutics, Inc.(CVKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cadrenal Therapeutics, Inc.(CVKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cadrenal Therapeutics, Inc.,CVKD,Cadrenal Therapeutics, Inc.股票,Cadrenal Therapeutics, Inc.股票老虎,Cadrenal Therapeutics, Inc.股票老虎国际,Cadrenal Therapeutics, Inc.行情,Cadrenal Therapeutics, Inc.股票行情,Cadrenal Therapeutics, Inc.股价,Cadrenal Therapeutics, Inc.股市,Cadrenal Therapeutics, Inc.股票价格,Cadrenal Therapeutics, Inc.股票交易,Cadrenal Therapeutics, Inc.股票购买,Cadrenal Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cadrenal Therapeutics, Inc.(CVKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cadrenal Therapeutics, Inc.(CVKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}